Action of low doses of Aspirin in Inflammation and Oxidative Stress induced by aβ_1-42 on Astrocytes in primary culture

Abstract

Aspirin has been used as anti-inflammatory and anti-aggregate for decades but the precise mechanism(s) of action after the presence of the toxic peptide Aβ1-42 in cultured astrocytes remains poorly resolved. Here we use low-doses of aspirin (10 -7 M) in astrocytes in primary culture in presence or absence of Aβ1-42 toxic peptide. We noted an increase of cell viability and proliferation with or without Aβ1-42 peptide presence in aspirin treated cells. In addition, a decrease in apoptosis, determined by Caspase 3 activity and the expression of Cyt c and Smac/Diablo, were detected. Also, aspirin diminished necrosis process (LDH levels), pro-inflammatory mediators (IL-β and TNF-α) and NF-ᴋB protein expression, increasing anti-inflammatory PPAR-γ protein expression, preventing Aβ1-42 toxic effects. Aspirin inhibited COX-2 and iNOS without changes in COX-1 expression, increasing anti-oxidant protein (Cu/Zn-SOD and Mn-SOD) expression in presence or absence of Aβ1-42. Taken together, our results show that aspirin, at low doses increases cell viability by decreasing inflammation and oxidative stress, preventing the deleterious effects of the Aβ1-42 peptide on astrocytes in primary culture. The use of low doses of aspirin may be more suitable for Alzheimer's disease.

Effectiveness and safety of aspirin combined with letrozole in the treatment of polycystic ovary syndrome: a systematic review and meta-analysis

“…Aspirin has antiplatelet and anticoagulant effects, and is widely used in the clinical treatment of rheumatism. It also has antiinflammatory, conventional antipyretic, and analgesic effects (24,25). In the treatment of PCOS, aspirin combined with letrozole achieves better therapeutic effects than letrozole alone.…”

Monitoring the Redox Status in Multiple Sclerosis

“…The oxidative state is induced by oxidative stressors either derived from xenobiotics outside of cells or produced from the activities of oxidative enzymes and essential cellular constituents [29] (Figure 1 (a)). Oxidative stressors are linked to several neurological diseases including Alzheimer's disease (AD), Parkinson's disease (PD), MS, depression, and amyotrophic lateral sclerosis [30,31,32]. Reductive stressors are products of antioxidant enzymes that generate antioxidants in response to regular oxidation activity and increased oxidative stress.…”

Identification of New Targets and the Virtual Screening of Lignans against Alzheimer’s Disease

“…COX-2, also known as prostaglandin H synthase 2 (PGHS-2), catalyzes the conversion from arachidonic acid and O 2 to PGs, which are important lipid mediators involved in numerous physiological aspects and pathophysiological processes. Under normal physiological conditions, COX-2 most often has a low level of expression, but this gene is highly induced in response to inflammation [ 71 – 73 ]. COX-1 is a constitutive enzyme, responsible for maintaining a basic level of PGs, to maintain physiological homeostasis, such as gastrointestinal integrity [ 73 , 74 ].…”

“…Under normal physiological conditions, COX-2 most often has a low level of expression, but this gene is highly induced in response to inflammation [ 71 – 73 ]. COX-1 is a constitutive enzyme, responsible for maintaining a basic level of PGs, to maintain physiological homeostasis, such as gastrointestinal integrity [ 73 , 74 ]. COX-1 and COX-2 catalyze the biosynthesis of prostaglandins, prostacyclins, and thromboxanes [ 68 ].…”